nodes	percent_of_prediction	percent_of_DWPC	metapath
Propantheline—CHRM3—nephrolithiasis	0.953	1	CbGaD
Propantheline—CHRM3—ureter—nephrolithiasis	0.0132	0.865	CbGeAlD
Propantheline—CHRM1—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00505	0.196	CbGpPWpGaD
Propantheline—CHRM2—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00498	0.194	CbGpPWpGaD
Propantheline—Isopropamide—CHRM3—nephrolithiasis	0.00445	1	CrCbGaD
Propantheline—CHRM1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00112	0.0433	CbGpPWpGaD
Propantheline—CHRM2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0011	0.0428	CbGpPWpGaD
Propantheline—CHRM3—renal system—nephrolithiasis	0.00105	0.0688	CbGeAlD
Propantheline—CHRM3—kidney—nephrolithiasis	0.00102	0.0665	CbGeAlD
Propantheline—CHRM1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.000938	0.0364	CbGpPWpGaD
Propantheline—CHRM2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.000926	0.036	CbGpPWpGaD
Propantheline—CHRM1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000684	0.0266	CbGpPWpGaD
Propantheline—CHRM3—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000682	0.0265	CbGpPWpGaD
Propantheline—CHRM2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000675	0.0262	CbGpPWpGaD
Propantheline—CHRM2—GPCRs, Other—CHRM3—nephrolithiasis	0.000489	0.019	CbGpPWpGaD
Propantheline—CHRM2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.000469	0.0182	CbGpPWpGaD
Propantheline—CHRM1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000385	0.015	CbGpPWpGaD
Propantheline—CHRM3—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000384	0.0149	CbGpPWpGaD
Propantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000345	0.0134	CbGpPWpGaD
Propantheline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000343	0.0133	CbGpPWpGaD
Propantheline—CHRM1—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000334	0.013	CbGpPWpGaD
Propantheline—CHRM1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000334	0.013	CbGpPWpGaD
Propantheline—CHRM2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00033	0.0128	CbGpPWpGaD
Propantheline—CHRM2—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.00033	0.0128	CbGpPWpGaD
Propantheline—CHRM1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000278	0.0108	CbGpPWpGaD
Propantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000249	0.00968	CbGpPWpGaD
Propantheline—CHRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000215	0.00837	CbGpPWpGaD
Propantheline—CHRM2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000213	0.00826	CbGpPWpGaD
Propantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000184	0.00717	CbGpPWpGaD
Propantheline—CHRM2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000182	0.00708	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000163	0.00632	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—RGS14—nephrolithiasis	0.000162	0.0063	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00016	0.00623	CbGpPWpGaD
Propantheline—Thirst—Hydrochlorothiazide—nephrolithiasis	0.000153	0.08	CcSEcCtD
Propantheline—CHRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.000148	0.00574	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—RGS14—nephrolithiasis	0.000147	0.00572	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—RGS14—nephrolithiasis	0.000146	0.00566	CbGpPWpGaD
Propantheline—CHRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00014	0.00546	CbGpPWpGaD
Propantheline—CHRM2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000139	0.00539	CbGpPWpGaD
Propantheline—CHRM1—GPCR ligand binding—PTH—nephrolithiasis	0.000128	0.00499	CbGpPWpGaD
Propantheline—CHRM3—GPCR ligand binding—PTH—nephrolithiasis	0.000128	0.00498	CbGpPWpGaD
Propantheline—CHRM2—GPCR ligand binding—PTH—nephrolithiasis	0.000127	0.00493	CbGpPWpGaD
Propantheline—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.000126	0.0662	CcSEcCtD
Propantheline—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.000126	0.0658	CcSEcCtD
Propantheline—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.000116	0.0606	CcSEcCtD
Propantheline—CHRM1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00011	0.00427	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—DGKH—nephrolithiasis	0.000109	0.00425	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000108	0.00421	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—GRHPR—nephrolithiasis	0.000104	0.00404	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ADCY10—nephrolithiasis	0.000103	0.00398	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ADCY10—nephrolithiasis	0.000102	0.00397	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	0.000101	0.00393	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	9.97e-05	0.00387	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—DGKH—nephrolithiasis	9.94e-05	0.00386	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	9.84e-05	0.00382	CbGpPWpGaD
Propantheline—Flushing—Hydrochlorothiazide—nephrolithiasis	9.33e-05	0.0489	CcSEcCtD
Propantheline—CHRM3—Metabolism—AGXT—nephrolithiasis	9.26e-05	0.0036	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	8.72e-05	0.00339	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—RGS14—nephrolithiasis	8.69e-05	0.00338	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	8.61e-05	0.00334	CbGpPWpGaD
Propantheline—Tension—Hydrochlorothiazide—nephrolithiasis	8.59e-05	0.045	CcSEcCtD
Propantheline—Nervousness—Hydrochlorothiazide—nephrolithiasis	8.5e-05	0.0445	CcSEcCtD
Propantheline—Vision blurred—Hydrochlorothiazide—nephrolithiasis	8.25e-05	0.0432	CcSEcCtD
Propantheline—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	7.94e-05	0.00308	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—APRT—nephrolithiasis	7.88e-05	0.00306	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—SLC26A1—nephrolithiasis	7.88e-05	0.00306	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	7.84e-05	0.00304	CbGpPWpGaD
Propantheline—Palpitations—Hydrochlorothiazide—nephrolithiasis	7.73e-05	0.0405	CcSEcCtD
Propantheline—Dry mouth—Hydrochlorothiazide—nephrolithiasis	7.29e-05	0.0382	CcSEcCtD
Propantheline—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	7.26e-05	0.00282	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PTH—nephrolithiasis	7.24e-05	0.00281	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	7.21e-05	0.0028	CbGpPWpGaD
Propantheline—Confusional state—Hydrochlorothiazide—nephrolithiasis	7.2e-05	0.0377	CcSEcCtD
Propantheline—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	7.17e-05	0.00278	CbGpPWpGaD
Propantheline—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	7.14e-05	0.0374	CcSEcCtD
Propantheline—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	7.12e-05	0.00276	CbGpPWpGaD
Propantheline—Tachycardia—Hydrochlorothiazide—nephrolithiasis	6.97e-05	0.0365	CcSEcCtD
Propantheline—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	6.59e-05	0.00256	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PTH—nephrolithiasis	6.57e-05	0.00255	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	6.51e-05	0.00253	CbGpPWpGaD
Propantheline—Insomnia—Hydrochlorothiazide—nephrolithiasis	6.46e-05	0.0338	CcSEcCtD
Propantheline—Somnolence—Hydrochlorothiazide—nephrolithiasis	6.35e-05	0.0333	CcSEcCtD
Propantheline—Constipation—Hydrochlorothiazide—nephrolithiasis	6.11e-05	0.032	CcSEcCtD
Propantheline—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.89e-05	0.00229	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	5.89e-05	0.00229	CbGpPWpGaD
Propantheline—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	5.89e-05	0.0308	CcSEcCtD
Propantheline—CHRM3—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.87e-05	0.00228	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—DGKH—nephrolithiasis	5.87e-05	0.00228	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.81e-05	0.00226	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	5.81e-05	0.00226	CbGpPWpGaD
Propantheline—Urticaria—Hydrochlorothiazide—nephrolithiasis	5.67e-05	0.0297	CcSEcCtD
Propantheline—CHRM3—Metabolism—AQP1—nephrolithiasis	5.61e-05	0.00218	CbGpPWpGaD
Propantheline—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	5.26e-05	0.0276	CcSEcCtD
Propantheline—Asthenia—Hydrochlorothiazide—nephrolithiasis	5.12e-05	0.0268	CcSEcCtD
Propantheline—Dizziness—Hydrochlorothiazide—nephrolithiasis	4.72e-05	0.0247	CcSEcCtD
Propantheline—Vomiting—Hydrochlorothiazide—nephrolithiasis	4.54e-05	0.0238	CcSEcCtD
Propantheline—Rash—Hydrochlorothiazide—nephrolithiasis	4.5e-05	0.0236	CcSEcCtD
Propantheline—Dermatitis—Hydrochlorothiazide—nephrolithiasis	4.5e-05	0.0236	CcSEcCtD
Propantheline—Headache—Hydrochlorothiazide—nephrolithiasis	4.47e-05	0.0234	CcSEcCtD
Propantheline—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	4.26e-05	0.00165	CbGpPWpGaD
Propantheline—Nausea—Hydrochlorothiazide—nephrolithiasis	4.24e-05	0.0222	CcSEcCtD
Propantheline—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	4.2e-05	0.00163	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PTH—nephrolithiasis	3.89e-05	0.00151	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PTH—nephrolithiasis	3.88e-05	0.00151	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PTH—nephrolithiasis	3.84e-05	0.00149	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	1.96e-05	0.00076	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SPP1—nephrolithiasis	1.95e-05	0.000757	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	1.93e-05	0.00075	CbGpPWpGaD
